首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Free neuropathology

缩写:

ISSN:2699-4445

e-ISSN:

IF/分区:0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引180
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
János Bencze,Woosung Seo,Abdul Hye et al. János Bencze et al.
Dementia is one of the major burdens of our aging society. According to certain predictions, the number of patients will double every 20 years. Although Alzheimer's disease (AD), as the most frequent neurodegenerative dementia, has been ext...
Pieter Wesseling Pieter Wesseling
This article briefly discusses 10 topics that were selected by the author as top 10 discoveries published in 2019 in the broader field of neuro-oncological pathology (so including neurosciences as well as clinical neuro-oncology but with im...
John L Robinson,Hayley Richardson,Sharon X Xie et al. John L Robinson et al.
Cerebrovascular lesions are prevalent in late life and frequently co-occur but the relationship to cognitive impairment is complicated by the lack of consensus around which lesions represent hallmark pathologies for vascular impairment, par...
Brenda D Moore,Yona Levites,Guilian Xu et al. Brenda D Moore et al.
Background: Seeding of pathology related to Alzheimer's disease (AD) and Lewy body disease (LBD) by tissue homogenates or purified protein aggregates in various model systems has revealed prion-like properties of these di...
My-le Nguyen,Emily Z Huie,Rachel A Whitmer et al. My-le Nguyen et al.
Alzheimer's disease (AD) and vascular dementia are two of the most prevalent dementias that afflict the aging population in the United States (US). Studies have made great strides in understanding the neuropathology of these diseases; howev...
Wouter Peelaerts,Liza Bergkvist,Sonia George et al. Wouter Peelaerts et al.
Epidemiological studies suggest a link between type-2 diabetes and Parkinson's disease (PD) risk. Treatment of type-2 diabetes with insulin sensitizing drugs lowers the risk of PD. We previously showed that the insulin sensitizing drug, MSD...